References
- 1World Health Organization. Malaria Fact Sheet. Geneva, Switzerland: World Health Organization; 2018.
- 2World Health Organization. World malaria report 2019. Geneva: World Health Organization; 2019.
- 3Tutu EO, Lawson B, Browne E. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana. Malar J. 2011; 10: 385. DOI: 10.1186/1475-2875-10-385
- 4Rouamba T, Samadoulougou S, Ouédraogo M, et al. Asymptomatic malaria and anaemia among pregnant women during high and low malaria transmission seasons in Burkina Faso: household-based cross-sectional surveys in Burkina Faso, 2013 and 2017. Malar J. 2021; 20. DOI: 10.1186/s12936-021-03703-4
- 5United States Agency for International Development.
Ghana Malaria Operational Plan-President’s Malaria Initiative; 2013 . FY2013. Accessed August 5, 2020.https://www.pmi.gov/docs/default-source/defaultdocumentlibrary/malariaoperationalplans/fy13/ghana_mop_fy13.pdf?sfvrsn=8 . - 6Boateng EY, Anyomi GE, Otoo J, Abaye DA.
Drivers of intermittent preventive treatment of malaria during pregnancy in Ghana: a generalized linear model with negative binomial approach . Applied Informatics. 2018(10). Berlin, Heidelberg: Springer. DOI: 10.1186/s40535-018-0057-6 - 7Exavery A, Mbaruku G, Mbuyita S, Makemba A, Kinyonge IP, Kweka H. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania. Malar J. 2014; 13: 22. DOI: 10.1186/1475-2875-13-22
- 8Ghana Health Service. National Malaria Control Program. Accra; 2016. Accessed November 8, 2020.
https://www.ghanahealthservice.org/downloads/NMCP_2015_ANNUAL_REPORT.pdf . - 9Addai-Mensah O, Annani-Akollor ME, Fondjo LA, et al. Regular antenatal attendance and education influence the uptake of intermittent preventive treatment of malaria in pregnancy: a cross-sectional study at the university hospital, Kumasi, Ghana. J Tropic Medic. 2018; 2018: 5019215. DOI: 10.1155/2018/5019215
- 10Tackie V, Seidu AA, Osei M. Factors influencing the uptake of intermittent preventive treatment of malaria among pregnant women: a cross-sectional study. J Public Health (Berl.); 2020. DOI: 10.1007/s10389-020-01234-x
- 11Amoako BK, Anto F. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana. BMC Preg Childbirth. 2021; 21: 105. DOI: 10.1186/s12884-021-03582-2
- 12Oppong FB, Gyaase S, Zandoh C, et al. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine pyrimethamine (SP): trends spanning 2011 and 2015. BMJ Open. 2019; 9:
e027946 . DOI: 10.1136/bmjopen-2018-027946 - 13Ghana Statistical Service. Ghana malaria indicator survey. Ghana Statistical Service: Accra, 2019. Accessed August 17, 2020.
https://dhsprogram.com/pubs/pdf/MIS35/MIS35.pdf - 14Ghana Statistical Service (GSS) and Macro International Inc. (MI). Ghana Demographic and Health Survey. Accra; 2017.
- 15Cochrane WG. Sampling techniques. New York: Wiley; 1963.
- 16Chico EB, et al. Sulfadoxine-pyrimethamine exhibits dose-response protection against adverse birth outcomes related to malaria and sexually transmitted and reproductive tract infection. Clinical Infectious Disease. 2017; 64(8): 1043–1051. DOI: 10.1093/cid/cix026
- 17Ibrahim H, Maya ET, Issah K, et al. Factors influencing uptake of intermittent preventive treatment of malaria in pregnancy using sulphadoxine pyrimethamine in Sunyani Municipality, Ghana. Pan Afric Medic J. 2017; 28: 122. DOI: 10.11604/pamj.2017.28.122.12611
- 18Darteh EKM, Buabeng I, Akuamoah-Boateng C.
Uptake of Intermittent Preventive Treatment in Pregnancy for Malaria in Ghana: Further Analysis of the 2016 Malaria Indicator Survey . DHS Working Paper No. 158. Rockville, Maryland, USA: ICF; 2019. DOI: 10.1007/s10389-020-01206-1 - 19Okethwangu D, et al. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda demographic and health survey, 2016. Malaria Journal. 2019; 18: 250. DOI: 10.1186/s12936-019-2883-y
- 20Basha GW. Factors affecting the utilization of a minimum of four antenatal Care Services in Ethiopia. Obstet Gynecol Int. 2019. Accessed September 15, 2020. DOI: 10.1155/2019/5036783
- 21Ayubu MB, Kidima WB. Monitoring compliance and acceptability of intermittent preventive treatment of malaria using Sulfadoxine Pyrimethamine after ten years of implementation in Tanzania. Malar Res Treat. 2017; 2017: 9761289. Accessed October 8, 2020. DOI: 10.1155/2017/9761289
- 22Adewole AO, et al. Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria. Pan Afric Medic J. 2019; 33: 101. DOI: 10.11604/pamj.2019.33.101.14800
- 23Anto F, Agongo IH, Asoala V, Awini E, Oduro AR. Intermittent preventive treatment of malaria in pregnancy: assessment of the Sulfadoxine-Pyrimethamine three-dose policy on birth outcomes in rural northern Ghana. J Tropic Medic. 2019. DOI: 10.1155/2019/6712685
- 24Amankwah S, Anto F. Factors associated with uptake of intermittent preventive treatment of malaria in pregnancy: a cross-sectional study in private health facilities in Tema Metropolis, Ghana. J Tropic Medic. 2019. DOI: 10.1155/2019/9278432